“`html
Investing in Four Promising Stocks Amid Market Volatility
Market volatility and current uncertainties can pose challenges for investors. However, this environment also presents excellent investment opportunities. Those willing to buy high-potential stocks and hold them for the long term could see substantial returns over the next decade, despite interim headwinds.
Here are four notable companies that are considered worthy investments for the long haul: Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Meta Platforms (NASDAQ: META), and Netflix (NASDAQ: NFLX).
1. Eli Lilly
Eli Lilly stands as a leading pharmaceutical company, particularly noted for its innovations in diabetes and weight management. Key products like Mounjaro and Zepbound are increasing in popularity, driving impressive sales growth.
Recently, Lilly reported positive results for orforglipron, an oral GLP-1 therapy, indicating further advancements in its product line. The company is also expanding into new areas, gaining recent approvals for Ebglyss, aimed at eczema. Additionally, Lilly’s oncology portfolio, including established drugs like Verzenio and Taltz, continues to contribute to robust revenue.
Financially, Lilly remains strong, consistently increasing its dividend, which has more than doubled in the past five years. Although shares dipped following recent earnings due to cautious guidance, this could represent a viable buying opportunity for long-term investors.
2. Vertex Pharmaceuticals
Vertex Pharmaceuticals boasts a dominant position in the cystic fibrosis (CF) market, effectively holding a monopoly on treatments. This unique position offers significant pricing power, with no successful challengers to its market share thus far.
Recent progress includes the December approval of Alyftrek, a next-generation CF therapy, which simplifies dosing. Vertex has diversified its portfolio significantly; in January, it received approval for Journavx, addressing acute pain. The company is actively developing therapies for unmet medical needs, well-positioned to make strides in various stages of clinical trials.
Despite some challenges that led to a post-earnings dip in its stock, Vertex’s pipeline and focus on innovation suggest it could deliver strong returns in the long run.
3. Meta Platforms
Meta Platforms has recently reported solid financial performance, further solidifying its status as a valuable investment. The company enjoys a vast ecosystem with 3.43 billion daily active users across its platforms, making it a prime target for advertisers.
Investments in artificial intelligence (AI) have fueled user growth and engagement, enhancing ad revenue. Management’s emphasis on AI demonstrates confidence in its potential as a long-term growth strategy, especially given Meta’s established presence in social media.
Moreover, Meta platforms continues to pursue opportunities in the metaverse and WhatsApp business messaging. While short-term momentum may fluctuate with economic conditions, the company’s long-term outlook remains strong.
4. Netflix
Netflix remains the leader in streaming, despite increasing competition from various platforms. Its strong brand identity has allowed it to keep its position in a crowded market, where “Netflix” has become synonymous with streaming.
The company capitalizes on user data to tailor content effectively, leading to numerous successful shows and films. Recently, Netflix has introduced an ad-supported tier and tightened password-sharing policies, both contributing to enhanced profitability and cash flow.
Netflix also believes it has only scratched the surface of a potential $650 billion revenue opportunity. As the streaming service has outperformed the market over the past two years, it offers significant upside for investors prepared to commit for five years or more.
Should you invest $1,000 in Eli Lilly right now?
Before making any purchasing decisions regarding shares in Eli Lilly, it is important to consider:
The Motley Fool…
“`
Analysts Uncover Top 10 Stocks for Future Investment
The Stock Advisor analyst team has pinpointed what they believe to be the 10 best stocks for investors to consider now. Notably, Eli Lilly is absent from this list. The stocks selected have the potential for significant returns in the years ahead.
Historical Performance Highlights
Reflecting on past recommendations, consider when Netflix was included on December 17, 2004. An investment of $1,000 at that time would have grown to approximately $623,103*.
Similarly, Nvidia became part of the list on April 15, 2005. An initial investment of $1,000 would have increased to around $717,471*.
Impressive Returns Compared to the Market
It is also important to note that Stock Advisor boasts an average total return of 909%, significantly outpacing the 162% return of the S&P 500. Investors are encouraged not to miss the latest top 10 list, which is accessible upon joining Stock Advisor.
*Stock Advisor returns as of May 5, 2025
Randi Zuckerberg, former director of market development at Facebook and sister of Meta Platforms CEO Mark Zuckerberg, serves on The Motley Fool’s board of directors. Prosper Junior Bakiny holds positions in Eli Lilly, Meta Platforms, and Vertex Pharmaceuticals. The Motley Fool has stakes in and recommends Meta Platforms, Netflix, and Vertex Pharmaceuticals. The Motley Fool adheres to a disclosure policy.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
